DDX30 Inhibitors
DDX30 inhibitors belong to a class of chemical compounds known for their ability to suppress the activity of the DDX30 protein. DDX30 is a member of the DEAD-box RNA helicase family, which plays a crucial role in various aspects of RNA metabolism, including RNA splicing, translation, and RNA decay. DDX30 is known to be involved in the assembly of spliceosomes, the molecular machines responsible for removing introns from pre-mRNA molecules. By inhibiting DDX30, these compounds can potentially disrupt the normal function of spliceosomes, leading to alterations in RNA splicing and subsequent changes in gene expression patterns.
The mechanism by which DDX30 inhibitors exert their effects is not yet fully understood, but it is believed to involve the interference with the ATPase activity of DDX30. ATP hydrolysis is a key step in the RNA unwinding activity of DEAD-box helicases, including DDX30. By inhibiting ATPase activity, these compounds may prevent DDX30 from unwinding RNA molecules, thereby disrupting its normal function in RNA metabolism. This could lead to aberrant RNA splicing and processing, potentially impacting various cellular processes dependent on accurate RNA processing. Research into DDX30 inhibitors is ongoing, with the aim of elucidating the precise mechanism of action and exploring their potential applications in modulating RNA metabolism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is known to intercalate into DNA, which can disrupt transcription. Its disruption of RNA polymerase activity could potentially decrease the expression of DHX30 at the transcriptional level. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a cytidine analog that incorporates into RNA and DNA. Its incorporation can cause demethylation of DNA, potentially altering the transcriptional profile of genes including DHX30. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin is a potent inhibitor of RNA polymerase II. By inhibiting this enzyme, it can suppress the transcription of many genes, potentially including DHX30. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and, thus, potentially inhibiting transcription processes. This may downregulate DHX30 expression indirectly. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin inhibits DNA polymerase α, leading to a halt in DNA replication. Stalled replication can affect gene expression, potentially including DHX30. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits the activity of positive transcription elongation factor b (P-TEFb). By doing so, it can affect the elongation phase of transcription, potentially downregulating DHX30. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin is an adenosine analog that, when incorporated, leads to premature termination of transcription. This can potentially limit the transcription of the DHX30 gene. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Flavopiridol is a kinase inhibitor that can inhibit CDK9, a component of P-TEFb. By affecting transcription elongation, it might reduce DHX30 expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcriptional activity of RNA polymerase II, and thus could reduce the expression of genes, potentially including DHX30. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Rocaglamide is known to inhibit the translation of specific mRNAs. While its specificity is not fully understood, it could potentially affect DHX30 mRNA translation. | ||||||